Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can)

Cancer Causes and Control

Volumn 22, Issue 5, 2011, Pages 743-751

  Almquist, Martin ^a   Johansen, Dorthe ^a   Björge, Tone ^b,k   Ulmer, Hanno ^c   Lindkvist, Björn ^d   Stocks, Tanja ^e,f   Hallmans, Göran ^e   Engeland, Anders ^b,k   Rapp, Kilian ^g   Jonsson, Håkan ^e   Selmer, Randi ^b   Diem, Guenter ^h   Häggström, Christel ^e   Tretli, Steinar ⁱ   Stattin, Pär ^e   Manjer, Jonas ^a,j  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

^g UNIVERSITY OF ULM   (Germany)

^h AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

ⁱ CANCER REGISTRY OF NORWAY   (Norway)

^j LUND UNIVERSITY   (Sweden)

^k UNIVERSITY OF BERGEN   (Norway)

more..

Author keywords

Cohort study; Epidemiology; Metabolic syndrome; Thyroid cancer

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUSTRIA; BLOOD PRESSURE; BODY MASS; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIFFERENTIATED THYROID CANCER; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SWEDEN; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AUSTRIA; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NORWAY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; THYROID NEOPLASMS; TRIGLYCERIDES;

EID: 79955775181     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9747-2     Document Type: Article

References (44)

1. L Davies HG Welch 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002 Jama 295 2164 2167 16684987 10.1001/jama.295.18.2164 1:CAS:528:DC%2BD28XksV2gtLg%3D
2. C Iribarren T Haselkorn IS Tekawa GD Friedman 2001 Cohort study of thyroid cancer in a San Francisco Bay area population Int J Cancer 93 745 750 11477590 10.1002/ijc.1377 1:CAS:528:DC%2BD3MXls1Wgt7c%3D (Pubitemid 32695128)
3. L Dal Maso C La Vecchia S Franceschi, et al. 2000 A pooled analysis of thyroid cancer studies. V. Anthropometric factors Cancer Causes Control 11 137 144 10710197 10.1023/A:1008938520101 1:STN:280:DC%2BD3c7ntlCgsw%3D%3D (Pubitemid 30088392)
4. Reaven GM (1997) Banting lecture 1988. Role of insulin resistance in human disease. Nutrition 13:65 discussion 64, 66
5. SS Daskalopoulou VG Athyros GD Kolovou KK Anagnostopoulou DP Mikhailidis 2006 Definitions of metabolic syndrome: where are we now? Curr Vasc Pharmacol 4 185 197 16842136 10.2174/157016106777698450 1:CAS:528:DC%2BD28XmtVaisrs%3D (Pubitemid 46785486)
6. G Hu Q Qiao J Tuomilehto 2005 The metabolic syndrome and cardiovascular risk Curr Diabetes Rev 1 137 143 18220589 10.2174/1573399054022820
7. RL Ahmed KH Schmitz KE Anderson WD Rosamond AR Folsom 2006 The metabolic syndrome and risk of incident colorectal cancer Cancer 107 28 36 16721800 10.1002/cncr.21950 (Pubitemid 43941640)
8. L Lund Haheim TF Wisloff I Holme P Nafstad 2006 Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years Am J Epidemiol 164 769 774 16952929 10.1093/aje/kwj284 1:STN:280:DC%2BD28rotVWqtA%3D%3D (Pubitemid 44522081)
9. H Tulinius N Sigfusson H Sigvaldason K Bjarnadottir L Tryggvadottir 1997 Risk factors for malignant diseases: a cohort study on a population of 22, 946 Icelanders Cancer Epidemiol Biomarkers Prev 6 863 873 9367058 1:STN:280:DyaK1c%2Fjtl2nsA%3D%3D (Pubitemid 27481633)
10. T Stocks W Borena S Strohmaier, et al. 2010 Cohort profile: the metabolic syndrome and cancer project (Me-Can) Int J Epidemiol 39 660 667 19380371 10.1093/ije/dyp186
11. K Rapp J Schroeder J Klenk, et al. 2006 Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria Diabetologia 49 945 952 16557372 10.1007/s00125-006-0207-6 1:CAS:528:DC%2BD28XjvFWrtLg%3D
12. P Leren EM Askevold OP Foss, et al. 1975 The Oslo study. Cardiovascular disease in middle-aged and young Oslo men Acta Med Scand Suppl 588 1 38 1062920 1:STN:280:DyaE287lslKisA%3D%3D
13. K Bjartveit OP Foss T Gjervig 1983 The cardiovascular disease study in Norwegian counties. Results from first screening Acta Med Scand Suppl 675 1 184 6581684 1:STN:280:DyaL2c7gtVyltg%3D%3D
14. O Naess AJ Sogaard E Arnesen, et al. 2008 Cohort profile: cohort of Norway (CONOR) Int J Epidemiol 37 481 485 17984119 10.1093/ije/dym217 (Pubitemid 351804000)
15. N Aires R Selmer D Thelle 2003 The validity of self-reported leisure time physical activity, and its relationship to serum cholesterol, blood pressure and body mass index. A population based study of 332, 182 men and women aged 40-42 years Eur J Epidemiol 18 479 485 12908712 10.1023/A:1024682523710 (Pubitemid 36899551)
16. B Lindahl L Weinehall K Asplund G Hallmans 1999 Screening for impaired glucose tolerance. Results from a population-based study in 21, 057 individuals Diabetes Care 22 1988 1992 10587831 10.2337/diacare.22.12.1988 1:STN:280:DC%2BD3c%2FlsFWnsQ%3D%3D (Pubitemid 30433977)
17. G Berglund KF Eriksson B Israelsson, et al. 1996 Cardiovascular risk groups and mortality in an urban swedish male population: the Malmo preventive project J Intern Med 239 489 497 8656142 10.1046/j.1365-2796.1996.483819000.x 1:STN:280:DyaK283msV2ktw%3D%3D
18. K Bjartveit OP Foss T Gjervig PG Lund-Larsen 1979 The cardiovascular disease study in Norwegian counties. Background and organization Acta Med Scand Suppl 634 1 70 293122 1:STN:280:DyaL3c%2FosVKgtQ%3D%3D
19. Percy C, Van Holten V, Muir C (eds) (1990) International classification of diseases for oncology. World Health Organization, Geneva
20. Welfare. TNBoHa (2002) [cited; Available from: http://www. socialstyrelsen.se/register/halsodataregister/cancerregistret/Documents/ Kodinstruktionen2002.pdf
21. Fibrinogen Studies Collaboration 2009 Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies Stat Med 28 1067 1092 10.1002/sim.3530
22. R Clarke M Shipley S Lewington, et al. 1999 Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 341 353 10453810 1:STN:280:DyaK1MzotFKisQ%3D%3D (Pubitemid 29383482)
23. AM Wood I White SG Thompson S Lewington J Danesh 2006 Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies Int J Epidemiol 35 1570 1578 17148467 10.1093/ije/dyl233 (Pubitemid 46178936)
24. SH Jee H Ohrr JW Sull, et al. 2005 Fasting serum glucose level and cancer risk in Korean men and women Jama 293 194 202 15644546 10.1001/jama.293.2.194 1:CAS:528:DC%2BD2MXktVyqsg%3D%3D (Pubitemid 40095870)
25. P Stattin O Björ P Ferrari, et al. 2007 Prospective study of hyperglycemia and cancer risk Diabetes Care 30 7 10.2337/dc06-0922 (Pubitemid 46354334)
26. T Stocks K Rapp T Bjorge, et al. 2009 Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts PLoS Med 6 e1000201 20027213 10.1371/journal.pmed. 1000201
27. YS Zhan L Feng SH Tang, et al. 2010 Glucose metabolism disorders in cancer patients in a Chinese population Med Oncol 27 177 184 19263254 10.1007/s12032-009-9189-9 1:CAS:528:DC%2BC3cXlsVSqsbw%3D
28. V Zivaljevic H Vlajinac R Jankovic, et al. 2004 Case-control study of anaplastic thyroid cancer Tumori 90 9 12 15143963 (Pubitemid 38541718)
29. G Randi M Ferraroni R Talamini, et al. 2008 Glycemic index, glycemic load and thyroid cancer risk Ann Oncol 19 380 383 17951595 10.1093/annonc/mdm433 1:STN:280:DC%2BD1c%2Fotlegsg%3D%3D (Pubitemid 351201724)
30. F Clavel-Chapelon G Guillas L Tondeur C Kernaleguen MC Boutron-Ruault 2010 Risk of differentiated thyroid cancer in relation to adult weight, height, and body shape over life: the French E3 N cohort Int J Cancer 126 2984 2990 19950225 1:CAS:528:DC%2BC3cXkvVOjs7c%3D
31. A Engeland S Tretli LA Akslen T Bjorge 2006 Body size and thyroid cancer in two million Norwegian men and women Br J Cancer 95 366 370 16832414 10.1038/sj.bjc.6603249 1:STN:280:DC%2BD28vms1OitQ%3D%3D (Pubitemid 44187599)
32. L Barlow K Westergren L Holmberg M Talback 2009 The completeness of the Swedish cancer register: a sample survey for year 1998 Acta Oncol 48 27 33 18767000 10.1080/02841860802247664
33. IK Larsen M Smastuen TB Johannesen, et al. 2009 Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness Eur J Cancer 45 1218 1231 19091545 10.1016/j.ejca.2008.10.037
34. E Fiore T Rago MA Provenzale, et al. 2009 Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role Endocr Relat Cancer 16 1251 1260 19528244 10.1677/ERC-09-0036 1:CAS:528: DC%2BC3cXhtFOnsr8%3D
35. S Ayturk A Gursoy A Kut, et al. 2009 Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area Eur J Endocrinol 161 599 605 19633072 10.1530/EJE-09-0410 1:CAS:528:DC%2BD1MXhtlOit7jL
36. A Roos SJ Bakker TP Links RO Gans BH Wolffenbuttel 2007 Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects J Clin Endocrinol Metab 92 491 496 17090642 10.1210/jc.2006-1718 1:CAS:528:DC%2BD2sXitVaksLo%3D
37. Garduno-Garcia Jde J, Alvirde-Garcia U, Lopez-Carrasco G et al (2010) TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol 163:273-278
38. E Negri L Dal Maso E Ron, et al. 1999 A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors Cancer Causes Control 10 143 155 10231163 10.1023/A:1008880429862 1:STN:280: DyaK1M3ks1Wqtg%3D%3D (Pubitemid 29161106)
39. C La Vecchia E Ron S Franceschi, et al. 1999 A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones Cancer Causes Control 10 157 166 10231164 10.1023/A:1008832513932 1:STN:280:DyaK1M3ks1Wqtw%3D%3D (Pubitemid 29161107)
40. F Saad L Gooren 2009 The role of testosterone in the metabolic syndrome: a review J Steroid Biochem Mol Biol 114 40 43 19444934 10.1016/j.jsbmb.2008.12. 022 1:CAS:528:DC%2BD1MXjvV2gs7Y%3D
41. AB Ropero P Alonso-Magdalena I Quesada A Nadal 2008 The role of estrogen receptors in the control of energy and glucose homeostasis Steroids 73 874 879 18249429 10.1016/j.steroids.2007.12.018 1:CAS:528:DC%2BD1cXmvFensLg%3D
42. SR Salpeter JM Walsh TM Ormiston, et al. 2006 Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women Diabetes Obes Metab 8 538 554 16918589 10.1111/j.1463-1326. 2005.00545.x 1:CAS:528:DC%2BD28XhtFSis7rM (Pubitemid 44184248)
43. Teede H, Deeks A, Moran L (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8:41
44. SJ Sondheimer 1991 Update on the metabolic effects of steroidal contraceptives Endocrinol Metab Clin North Am 20 911 923 1778182 1:CAS:528:DyaK38XktVSqtL8%3D